Oppenheimer Downgrades Catalyst Pharmaceuticals to Market Perform From Outperform

-- Catalyst Pharmaceuticals (CPRX) has an average rating of overweight and mean price target of $33.83, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Price: $31.23, Change: $+0.71, Percent Change: +2.33%